AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT developer OpenAI ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...
The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...
Lynx Investment Advisory increased its stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 1.3% in the 4th quarter, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results